Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 22.29 is 66% above its 5-year average of 13.43, near the high end of its 5-year range (0.61–29.15).
As of the fiscal period ended Tuesday, June 30, 2026. 8.79% below its 12-month average of 24.44.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 22.29.
QUICK RATIO (ACID-TEST)
22.29
QUICK RATIO (ACID-TEST) AVG TTM
24.44
QUICK RATIO (ACID-TEST) AVG 3Y
16.38
QUICK RATIO (ACID-TEST) AVG 5Y
13.43
QUICK RATIO (ACID-TEST) AVG 10Y
13.53
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-8.79%
CURRENT VS 3Y AVG
+36.07%
CURRENT VS 5Y AVG
+66.00%
CURRENT VS 10Y AVG
+64.68%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+564.30%
vs the sector median at left
Tectonic Therapeutic, Inc.
Market Cap
$422.86M
Quick Ratio (Acid-Test)
22.29
TTM Avg
24.44
3Y Avg
16.38
5Y Avg
13.43
Market Cap
$422.72M
Quick Ratio (Acid-Test)
1.37
TTM Avg
1.43
3Y Avg
1.40
5Y Avg
1.53
Market Cap
$424.10M
Quick Ratio (Acid-Test)
3.35
TTM Avg
2.92
3Y Avg
4.56
5Y Avg
5.25
Market Cap
$419.87M
Quick Ratio (Acid-Test)
25.05
TTM Avg
8.87
3Y Avg
10.83
5Y Avg
12.06
Market Cap
$426.51M
Quick Ratio (Acid-Test)
3.28
TTM Avg
10.55
3Y Avg
42.24
5Y Avg
29.93
Market Cap
$418.95M
Quick Ratio (Acid-Test)
3.19
TTM Avg
3.65
3Y Avg
4.66
5Y Avg
6.11
Market Cap
$416.27M
Quick Ratio (Acid-Test)
6.40
TTM Avg
3.40
3Y Avg
4.68
5Y Avg
4.62
Market Cap
$415.98M
Quick Ratio (Acid-Test)
9.44
TTM Avg
11.90
3Y Avg
14.34
5Y Avg
23.42
Market Cap
$431.97M
Quick Ratio (Acid-Test)
3.91
TTM Avg
4.41
3Y Avg
5.46
5Y Avg
6.71
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tectonic Therapeutic, Inc. (TECX) | $422.86M | 22.29 | 24.44 | 16.38 | 13.43 |
| Tilray Brands, Inc. (TLRY)vs › | $422.72M | 1.37 | 1.43 | 1.40 | 1.53 |
| NeoGenomics, Inc. (NEO)vs › | $424.10M | 3.35 | 2.92 | 4.56 | 5.25 |
| Prothena Corporation plc (PRTA)vs › | $419.87M | 25.05 | 8.87 | 10.83 | 12.06 |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $426.51M | 3.28 | 10.55 | 42.24 | 29.93 |
| Editas Medicine, Inc. (EDIT)vs › | $418.95M | 3.19 | 3.65 | 4.66 | 6.11 |
| Senseonics Holdings, Inc. (SENS)vs › | $416.27M | 6.40 | 3.40 | 4.68 | 4.62 |
| Rezolute, Inc. (RZLT)vs › | $415.98M | 9.44 | 11.90 | 14.34 | 23.42 |
| NeuroPace, Inc. (NPCE)vs › | $431.97M | 3.91 | 4.41 | 5.46 | 6.71 |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | 16.52 | 13.61 | 8.86 | 8.86 |
Quick Ratio
22.29
Excludes inventory
Current Ratio
22.29
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 22.29 |
| 2026-03-31 | 18.51 |
| 2025-12-31 | 26.63 |
| 2025-09-30 | 29.15 |
| 2025-06-30 | 25.60 |
| 2025-03-31 | 22.92 |
| 2024-12-31 | 12.65 |
| 2024-09-30 | 9.39 |
| 2024-06-30 | 7.21 |
| 2024-03-31 | 26.17 |
| 2023-12-31 | 0.76 |
| 2023-09-30 | 0.61 |
| 2023-06-30 | 11.05 |
| 2023-03-31 | 5.40 |
| 2022-12-31 | 4.73 |
| 2022-09-30 | 7.80 |
| 2022-06-30 | 11.11 |
| 2022-03-31 | 9.98 |
| 2021-12-31 | 6.95 |
| 2021-09-30 | 9.29 |
| 2021-06-30 | 13.77 |
| 2021-03-31 | 18.96 |
| 2020-12-31 | 16.09 |
| 2020-09-30 | 9.14 |
| 2020-06-30 | 16.29 |
| 2020-03-31 | 20.77 |
| 2019-12-31 | 13.96 |
| 2019-09-30 | 21.56 |
| 2019-06-30 | 11.20 |
| 2019-03-31 | 11.44 |
| 2018-12-31 | 12.26 |
| 2018-09-30 | 25.81 |
| 2018-06-30 | 16.21 |
| 2018-03-31 | 11.56 |
| 2017-09-30 | 0.00 |
| 2017-03-31 | 0.00 |
